Seaport Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
SPTX Nasdaq 2830 www.seaporttx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Seaport Therapeutics, Inc.

PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers - Jun 9th, 2026 12:00 am
Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress - Jun 8th, 2026 5:05 am
Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers - Jun 8th, 2026 5:00 am
Seaport Therapeutics to Participate in Two Upcoming Investor Conferences - Jun 1st, 2026 5:00 am
Assessing Seaport Therapeutics (SPTX) Valuation After Its Recent 10.2% One Day Share Price Move - May 4th, 2026 1:09 am